您当前的位置：
首页 >
文章列表页 >
Clinical Effect of Runzaoling Combined with Iguratimod on Primary Sjögren's Syndrome
更新时间：2023-12-19
|

    • Clinical Effect of Runzaoling Combined with Iguratimod on Primary Sjögren's Syndrome

    • “A study conducted by the Rheumatology and Immunology Department of the Second Affiliated Hospital of Guizhou University of Chinese Medicine found that the combination of alamod and traditional Chinese medicine Runzaoling compound has good clinical efficacy and safety in the treatment of primary Sjogren's syndrome.”
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 30, Issue 2, Pages: 127-133(2024)

    • DOI：10.13422/j.cnki.syfjx.20240398    

      CLC： R242;R2-0;R2-031;R593;R24

    • Received：05 June 2023，

      Published Online：08 November 2023，

      Published：20 January 2024

    移动端阅览

  • LUO Linru,MA Xi,ZENG Ping,et al.Clinical Effect of Runzaoling Combined with Iguratimod on Primary Sjögren's Syndrome[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(02):127-133. DOI： 10.13422/j.cnki.syfjx.20240398.

  •  
  •  

0

Views

26

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Randomized， Open， Parallel Controlled， Multi-center Study for Efficacy and Safety of Lianhua Qingke Tablets in Treatment of Acute Bronchitis in Children with Syndrome of Phlegm-heat Obstructing Lung
Efficacy of Fuzheng Huayu Tablets for Treating Pulmonary Inflammation in COVID-19 Patients
Safe Application of Danshen Injection

Related Author

LI Nan
GENG Shaoyi
WANG Xiaofang
ZHANG Xiaowei
JIA Lixia
KANG Rongzhen
DU Xiangjun
WU Lichun

Related Institution

Shijiazhuang Maternal and Child Health Care Hospital
Hebei Province Hospital of Traditional Chinese Medicine(TCM)
Shijiazhuang Hospital of TCM
The Third Hospital of Shijiazhuang
Jinzhou People's Hospital
0